How Amazon could crack the US$300bil pharmacy market


The PillPack Inc. application is displayed on an Apple Inc. iPhone in an arranged photograph taken in Washington, D.C., U.S., on Thursday, June 28, 2018. Amazon.com Inc. agreed to buy the online pharmacy startup PillPack, jumping into the health-care business with a deal that will give the retail giant an immediate nationwide drug network. Photographer: Andrew Harrer/Bloomberg

Amazon.com Inc. is buying its way into the pharmacy business. Now the question is, how big can it get? 

PillPack, the startup pharmacy that Amazon is buying for about US$1bil (RM4bil), for now focuses on a narrow segment of patients who are on many different medications. It packages pills in individual packets that help people remember when to take their drugs every day, a common challenge for people taking, for example, drugs for diabetes, high cholesterol and blood pressure. 

Limited time offer:
Just RM5 per month.

Monthly Plan

RM13.90/month
RM5/month

Billed as RM5/month for the 1st 6 months then RM13.90 thereafters.

Annual Plan

RM12.33/month

Billed as RM148.00/year

1 month

Free Trial

For new subscribers only


Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
   

Next In Tech News

Amazon Prime Video to exclusively stream two NHL seasons in Canada
T-Mobile to invest $950 million in venture with EQT to buy fiber optic network provider Lumos
Hertz Global eyes worst day on record as EV rental business falters
EU court adviser backs data privacy activist Schrems in Meta fight
Spotify says Apple has rejected its app update with price information for EU users
Amazon to invest $11 billion in Indiana to build data centers
IBM falls as enterprise-spending constraints choke consulting demand
Net neutrality rules to be restored in US agency vote
India's Tech Mahindra misses Q4 revenue view on weak communications segment
Explainer-Where are Wall Street's analyst notes on Trump's Truth Social?

Others Also Read